Additionally, doctors sometimes prescribe microdosing once their patient has reached their target weight
Participants who stopped semaglutide at week 68 (orange) regained most of their lost weight within a year net loss shrank from 17.3% to 5.6% by week 120
In response to 8 weeks of L-citrulline supplementation and RT for body composition, our present results indicate that neither GSH + CIT or CIT-malate had any preferential and significant effect on total body mass, fat mass, and total body water
This question concerns many patients considering GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) for obesity management
10.1210/jc.2011-0555 56 IwataN.HasegawaT.FujitaS.NagaoS.NakanoY.NadaT.et al (2018)
What does not change is the value of tracking a given patients actual reported response